96 results
8-K
EX-99.1
OCGN
Ocugen Inc
14 May 24
Ocugen Provides Business Update with First Quarter 2024 Financial Results
3:54pm
Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets
MALVERN, Pa., May 14, 2024 (GLOBE NEWSWIRE) – Ocugen, Inc
8-K
EX-99.1
3nj7xxz
8 Nov 22
Other Events
9:12am
8-K
EX-99.2
xv4r0 0he398ewqr
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.3
wxv zh7cd
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
80tf4gokptbi03acvr
26 Aug 22
Other Events
5:04pm
8-K
EX-99.1
mehj29ksec zmhfqm0rs
17 Aug 22
Other Events
4:03pm
8-K
EX-99.1
3n5vf3m1g36frwag
16 Aug 22
Other Events
4:09pm
8-K
EX-99.3
x0g jdq41ortut
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
EX-99.1
jaaa30jakqs zmrr6zmr
20 Apr 22
Other Events
5:11pm
8-K
EX-99.1
ln3qrgl py
4 Apr 22
Other Events
5:01pm
8-K
EX-99.1
282dnaf w4bu23vy4ag
11 Mar 22
Other Events
4:24pm
8-K
EX-99.1
2uvokrkc qsee2i0ntw
22 Feb 22
Other Events
7:39am